Shanghai Yizhong Pharmaceutical Co Ltd (688091) — Working Capital to Net Assets Ratio
Shanghai Yizhong Pharmaceutical Co Ltd (688091) has a Working Capital to Net Assets ratio of 41.8% as of September 2025. Working capital of CN¥610.92 Million (current assets of CN¥690.56 Million minus current liabilities of CN¥79.64 Million) is measured against net assets of CN¥1.46 Billion. A higher ratio indicates strong short-term liquidity financed by the equity base. See Shanghai Yizhong Pharmaceutical Co Ltd balance sheet independence to measure how much of total assets are equity-financed.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Shanghai Yizhong Pharmaceutical Co Ltd Working Capital to Net Assets (2017–2024)
This chart shows how Shanghai Yizhong Pharmaceutical Co Ltd's Working Capital to Net Assets ratio has evolved across 8 annual periods from 2017 to 2024. As of September 2025, the ratio stands at 41.8%, reflecting working capital of CN¥610.92 Million against net assets of CN¥1.46 Billion CNY. Check Shanghai Yizhong Pharmaceutical Co Ltd tangible equity quality to evaluate the tangible quality of the company's equity base.
Annual Working Capital to Net Assets for Shanghai Yizhong Pharmaceutical Co Ltd (2017–2024)
The table below presents the year-by-year Working Capital to Net Assets ratio for Shanghai Yizhong Pharmaceutical Co Ltd from 2017 to 2024, covering 8 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For live market cap and the full company profile, see 688091 company net worth.
| Year | WC/NA Ratio | Working Capital (CNY) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2024 | 52.4% | CN¥736.76 Million | CN¥1.41 Billion | CN¥776.21 Million | CN¥39.45 Million | ▼ -36.9 pp |
| 2023 | 89.4% | CN¥1.31 Billion | CN¥1.46 Billion | CN¥1.41 Billion | CN¥103.98 Million | ▲ +0.7 pp |
| 2022 | 88.7% | CN¥1.17 Billion | CN¥1.32 Billion | CN¥1.20 Billion | CN¥29.86 Million | ▲ +6.0 pp |
| 2021 | 82.7% | CN¥972.45 Million | CN¥1.18 Billion | CN¥993.55 Million | CN¥21.10 Million | ▲ +63.7 pp |
| 2020 | 19.0% | CN¥46.22 Million | CN¥243.51 Million | CN¥57.73 Million | CN¥11.51 Million | ▼ -30.2 pp |
| 2019 | 49.1% | CN¥130.41 Million | CN¥265.35 Million | CN¥138.04 Million | CN¥7.63 Million | ▼ -23.7 pp |
| 2018 | 72.8% | CN¥154.47 Million | CN¥212.18 Million | CN¥166.16 Million | CN¥11.69 Million | ▲ +25.8 pp |
| 2017 | 47.0% | CN¥92.92 Million | CN¥197.57 Million | CN¥103.32 Million | CN¥10.40 Million | — |